Obinutuzumab (GA101) Plus CHOP Or FC In Relapsed/Refractory Follicular Lymphoma: Final Data From The Maintenance Phase Of The Phase 1b GAUDI Study (BO21000)
作者:
Wassner-Fritsch, Elisabeth
Wassner-Fritsch, Elisabeth
D O I:
10.1182/blood.V122.21.1814.1814